Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 66.05M shares outstanding
USEvolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
Albert G. White III
Director; President & Chief Executive Officer
Brady Stewart
Chief Executive Officer of Bay FC; Director
David Gill
Director
David Moatazedi
President, Chief Executive Officer & Director
Employees
353
Country
US
Sector
Healthcare
Website
evolus.com
Loading congressional disclosures…
based on 66.05M shares outstanding
US30d Avg
720.36K
60d Avg
843.96K
90d Avg
890.97K
